TrialDrugs in R&D2017

A Randomized Multiple Dose Pharmacokinetic Study of a Novel PDE10A Inhibitor TAK-063 in Subjects with Stable Schizophrenia and Japanese Subjects and Modeling of Exposure Relationships to Adverse Events.

Paul Goldsmith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.